Table 1.

Patients’ clinicopathological characteristics. Sex, age at treatment, histotype, chemotherapy, radiotherapy, and tumor burden of enrolled MFS and UPS patients are provided.

Sex Male 20 (MFS 10, UPS 10) (51.3%)

Female 19 (MFS 11, UPS 9) (48.7%)

Age at treatment

Median ± SD (range) 69.19 ± 13.58 (44–90)

Histotype

Myxofibrosarcoma 19 (46.7%)

Undifferentiated Pleomorphic Sarcoma 20 (53.3%)

Chemotherapy

Anthracycline-based regimen (4) (10.2%) Radiotherapy Adjuvant RT (9) (23.1%)

Tumor burden

Recurrence (15) (38.5%)

Primitive (24) (61.5%)